Healthy Mind Healthy You: A Study of Mindfulness
1 other identifier
interventional
4,412
1 country
1
Brief Summary
Most people experience stress at some point in their lives. Stress, especially when severe, can not only make you feel bad, it can also worsen existing health problems like heart disease, type 2 diabetes, obesity, high blood pressure, depression, and even cancer. Healthy Mind, Healthy You is a new study about how mindfulness can help people cope with stress. Funded by the Patient Centered Outcome Research Institute (PCORI) and involving 19 Patient Powered Research Networks (PPRNs), Healthy Mind Healthy You will be able to study the effects of mindfulness on a wide variety of populations and conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2017
CompletedFirst Posted
Study publicly available on registry
February 18, 2019
CompletedStudy Start
First participant enrolled
February 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2020
CompletedResults Posted
Study results publicly available
May 13, 2021
CompletedMay 13, 2021
April 1, 2021
12 months
October 31, 2017
September 15, 2020
April 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Estimated Weekly Change on World Health Organization-5 (WHO-5)
The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. We used linear mixed effects models to examine the effect of the interventions on weekly WHO-5 scores. Change = estimated average weekly change during time frame.
Baseline to 8 Weeks, Baseline to 20 Weeks
Secondary Outcomes (5)
Estimated Weekly Change on Perceived Stress Scale (PSS)
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change on Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated
Baseline to 8 Weeks, Baseline to 20 Weeks
Other Outcomes (6)
Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Age
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Perceived Stress Scale (PSS)
Baseline to 8 Weeks, Baseline to 20 Weeks
Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form (PROMIS: EDD)
Baseline to 8 Weeks, Baseline to 20 Weeks
- +3 more other outcomes
Study Arms (2)
Mindfulness-Based Cognitive Therapy
EXPERIMENTAL8 sessions of online mindfulness-based cognitive therapy
Brief Mindfulness
EXPERIMENTAL3 sessions of online mindfulness therapy
Interventions
8 sessions of online mindfulness-based cognitive therapy
Eligibility Criteria
You may qualify if:
- Must be a member (patient/member of special population or caregiver) of one of the 19 PCORI Patient-Powered Research Networks (PPRN)
- Must be age 18 or older
You may not qualify if:
- Under the age of 18 years
- Unable to read, understand, and/or participate in mindfulness exercises
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- University of South Floridacollaborator
- Global Healthy Living Foundationcollaborator
- University of North Carolinacollaborator
- University of California, Los Angelescollaborator
- Genetic Alliancecollaborator
- COPD Foundationcollaborator
- The Duchenne Registrycollaborator
- University of California, San Franciscocollaborator
- Children's Hospital Medical Center, Cincinnaticollaborator
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.collaborator
- Accelerated Cure Project for Multiple Sclerosiscollaborator
- Mayo Cliniccollaborator
- Phelan-McDermid Syndrome Foundationcollaborator
- Immune Deficiency Foundationcollaborator
- Brigham and Women's Hospitalcollaborator
- University of Pennsylvaniacollaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (1)
Sylvia LG, Lunn MR, Obedin-Maliver J, McBurney RN, Nowell WB, Nosheny RL, Mularski RA, Long MD, Merkel PA, Pletcher MJ, Tovey RE, Scalchunes C, Sutphen R, Martin AS, Horn EJ, O'Boyle M, Pitch L, Seid M, Redline S, Greenebaum S, George N, French NJ, Faria CM, Puvanich N, Rabideau DJ, Selvaggi CA, Yu C, Faraone SV, Venkatachalam S, McCall D, Terry SF, Deckersbach T, Nierenberg AA. Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial. J Med Internet Res. 2022 Sep 12;24(9):e35620. doi: 10.2196/35620.
PMID: 36094813DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Despite having a wide range of clinical and non-clinical samples represented in this study, the sample generalizability was limited in regards to race and gender. A second limitation was not including support for participants to access the study (e.g., technical support, translated versions into other languages) as well as to engage with the study interventions.
Results Point of Contact
- Title
- Andrew Nierenberg
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew A Nierenberg, MD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Dauten Family Center for Bipolar Treatment Innovation
Study Record Dates
First Submitted
October 31, 2017
First Posted
February 18, 2019
Study Start
February 27, 2019
Primary Completion
February 19, 2020
Study Completion
February 19, 2020
Last Updated
May 13, 2021
Results First Posted
May 13, 2021
Record last verified: 2021-04